Cargando…
Activating Mutations in TOR Are in Similar Structures As Oncogenic Mutations in PI3KCα
[Image: see text] TOR (Target of Rapamycin) is a highly conserved Ser/Thr kinase and a central controller of cell growth. Using the crystal structure of the related lipid kinase PI3KCγ, we built a model of the catalytic region of TOR, from the FAT domain to near the end of the FATC domain. The model...
Autores principales: | Sturgill, Thomas W., Hall, Michael N. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2009
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2796128/ https://www.ncbi.nlm.nih.gov/pubmed/19902965 http://dx.doi.org/10.1021/cb900193e |
Ejemplares similares
-
Allosteric activation of PI3Kα by oncogenic mutations
por: Burke, John E., et al.
Publicado: (2013) -
The DHAV-1 protein VP1 interacts with PI3KC3 to induce autophagy through the PI3KC3 complex
por: Li, Juan, et al.
Publicado: (2022) -
Oncogenic Mutations of p110α Isoform of PI 3-Kinase Upregulate Its Protein Kinase Activity
por: Buchanan, Christina M., et al.
Publicado: (2013) -
Identification and Characterization of Two Novel Oncogenic mTOR Mutations
por: Murugan, Avaniyapuram Kannan, et al.
Publicado: (2019) -
KC DUBE AWARDS
Publicado: (2019)